Ziopharm Oncology (ZIOP) Tops Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q4 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- DA Davidson Reiterates Neutral Rating on Nebius Group (NBIS)
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
